
Latest
PLSE Stock: Pulse Hits 164-Patient Heart Trial Goal
PLSE stock gained a clinical catalyst after Pulse Biosciences enrolled 164 patients across 15 sites in its pivotal NANOPULSE-AF study.

PLSE stock gained a clinical catalyst after Pulse Biosciences enrolled 164 patients across 15 sites in its pivotal NANOPULSE-AF study.